Navigation Links
Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
Date:4/14/2008

- Data Presented at AACR Annual Meeting Late-Breaking Clinical Trials

Session -

SAN FRANCISCO and SAN DIEGO, April 14 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that data from an ongoing Phase 1-2 clinical trial showed that the Company's novel androgen receptor antagonist, MDV3100, continued to reduce serum levels of prostate specific antigen (PSA), a marker of tumor growth, in the lowest expanded dose group tested after three months of treatment. Over-expression of the androgen receptor is believed to contribute to the progression of castration-resistant prostate cancer. These observed declines were consistent with the inhibition of androgen receptor signaling. MDV3100 continued to be well-tolerated in all dose groups.

The data were presented as part of a special late-breaker clinical plenary session at the American Association for Cancer Research (AACR) Annual Meeting in San Diego. The oral presentation, entitled "Phase I-II study of the androgen receptor antagonist MDV3100 in castration-resistant prostate cancer," was presented by Howard Scher, M.D., chief of the Genitourinary Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York.

"The declines in PSA observed thus far and the general tolerability of this treatment are encouraging, and further data currently being generated will clarify its role as a potential therapy for patients with castration-resistant prostate cancer," said Dr. Scher.

"We continue to be encouraged by the results observed at this low dose of MDV3100. In addition, we are testing higher doses to assess a dose response," said David Hung, M.D., president and
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medivation Announces Senior Management Promotions
2. Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
3. Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
5. Boston Scientific Announces Japanese Approval of Heart Failure Lead
6. Vasogen Announces Implementation of Strategic Restructuring Plan
7. Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
8. EXL Announces Appointment of Rembert de Villa as Head of Transformation Services
9. Botaneco Announces Launch of Second Generation Oleosome Product
10. YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR TWO OF ITS ANTI-CANCER DRUGS AT AACR ANNUAL MEETING
11. Signalife Announces Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... GenoSpace , a precision medicine software company that has developed ... of genomic, imaging and other biomedical data in research and ... , CEO of Aspera, an IBM Company, to its board ... "We are pleased to welcome Michelle ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 The report ... by Product Type & Provider Type - Global Advancements, ... market with an in-depth analysis and forecasting of revenues. ... spread through 221 pages and in-depth TOC on “Service ...
(Date:12/24/2014)... and NEW YORK , Dec. 24, 2014 ... advancing patient care in critical areas, announced the closing of ... and warrants to purchase up to an aggregate 3,500,000 shares ... share and $.01 per warrant.  The warrants have a per ...
(Date:12/24/2014)... , Dec. 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade hypothermic storage and ... for cells and tissues  ("BioLife" or the "Company"), today ... Stockholders on May 4, 2015 (the "Annual Meeting"). ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
... Nov. 7The search for innovative, cost-effective and ... are the focus of ongoing intense worldwide ... diodes (OLEDs)lightweight, potentially flexible, cheap-to-fabricate and highly ... in alternative energy lighting and display applications. ...
... YORK, Nov. 8, 2011 Reportlinker.com announces that ... its catalogue: Global Apoptosis Industry ... This report analyzes the worldwide markets for Apoptosis ... analytics for the US, Canada, Europe, Asia Pacific, ...
... Santo VC GmbH has acquired a EUR 20 million ... also secured an option for further capital increases in the ... its existing investment in AFFiRiS by EUR 5 million through ... an additional EUR 25 million in   equity at its ...
Cached Biology Technology:Organic light-emitting diodes 2Organic light-emitting diodes 3Global Apoptosis Industry 2Global Apoptosis Industry 3Global Apoptosis Industry 4Global Apoptosis Industry 5Global Apoptosis Industry 6Global Apoptosis Industry 7Global Apoptosis Industry 8Global Apoptosis Industry 9Global Apoptosis Industry 10Global Apoptosis Industry 11AFFiRiS AG: Capital Increase: AFFiRiS Brings Santo VC and MIG 11 on Board 2AFFiRiS AG: Capital Increase: AFFiRiS Brings Santo VC and MIG 11 on Board 3AFFiRiS AG: Capital Increase: AFFiRiS Brings Santo VC and MIG 11 on Board 4
(Date:1/22/2015)... MUNICH , January 22, 2015 ... its tenth year  The European Patent Office to present ... Two British nominations to be featured: Christofer Toumazou ... week featuring former finalists and winners of the Award   ...
(Date:12/24/2014)...  Since its launch in December 2014, the 1U™ ... of trying to remember their usernames and passwords through replacing ... smartphones. To assist people who have struggled to remember usernames ... 1U and focuses on redefining identity, announced today that it ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... "iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & ... http://photos.prnewswire.com/prnh/20130307/600769 ... introduced the fingerprint reading feature with the iPhone 5S. ...
Breaking Biology News(10 mins):Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 31U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2
... expert working group of the International Osteoporosis Foundation ... and Laboratory Medicine (IFCC) has released a new ... turnover markers (BTMs) in fracture risk prediction and ... research priorities and recommends that specific markers be ...
... at Oregon State University have helped sequence the genome ... improvements to related fruits like apples, peaches and pears. ... Nature Genetics . "This will accelerate research ... said OSU plant molecular biologist Todd Mockler, one of ...
... consortium of researchers working across five continents, including BBSRC-funded ... the wild strawberry ( Fragaria vesca ). The research, ... will help strawberry breeders to develop disease resistance ... Dr Dan Sargent, based at East Malling Research (EMR) ...
Cached Biology News:Standardized protocols would greatly enhance clinical and research potential of BTMs 2OSU helps decode strawberry genome in bid to improve fruit 2OSU helps decode strawberry genome in bid to improve fruit 3UK researchers contribute to sequencing strawberry genome 2
Human PDGF, CF...
... For the ultimate in utility and flexibility ... meet the needs of the researcher. They ... dimensions or as sheet material that can ... These isolators are autoclavable and non-cytotoxic and ...
... The mycobacteria ... other cells to the injection site which ... Complete Freund's Adjuvant is used for the ... for the subsequent boosts. Antigens (preferably in ...
The ELISA Kit for Hepatitis B Surface Antigen (HBsAg) is an in vitro enzyme immunoassay for the detection of HBsAg in human serum or plasma....
Biology Products: